Rethinking how we assess
heart failure risk.

Designed to give clinicians a new insight at the first point of care, or through remote monitoring.

Selected, MedTech Innovator
Asia Pacific 2025

Our AI ECG technology is an investigational device. It has not been approved or cleared by the FDA or any other regulatory authority for diagnostic use.

Heart failure is often caught too late.

It's more common than people realize, and often just as easy to overlook.
HFpEF, heart failure with preserved ejection fraction, is especially likely to slip past conventional tests. It routinely goes undiagnosed until it reaches acute care, where mortality risk is already high.

1 in 4
adults will develop heart failure in their lifetime1
>Half
of heart failure cases are HFpEF2, the type conventional tools most often miss
46%
had documented HF symptoms in the 6 months before their diagnosis3

Solution

Our AI ECG technology for heart failure

Designed to assess heart failure risk from a 30-second single-lead ECG wherever a Lead I is captured.

AI ECG analysis diagram
01
Anywhere an ECG is captured

Designed for Lead I from hospital 12-lead ECGs and from wearables.

02
Both HFrEF and HFpEF

Research results reported for heart failure overall and for the HFpEF subgroup.

03
No new hardware required

Software-only. Designed to run on existing 12-lead ECG systems (cloud, on-premises, or embedded) and on wearables.

Published research
JACC: Basic to Translational Science (2024) · International Journal of Cardiology (2025)

Latest news

Let's talk.

We welcome inquiries from clinicians, researchers, investors, and potential partners.

Clinical Partnership Investors Press

References

  1. Fonarow GC, et al. HF Stats 2025: Heart Failure Epidemiology and Outcomes Statistics, An Updated 2025 Report from the Heart Failure Society of America. J Card Fail. 2026.
  2. Kittleson MM, et al. Management of Heart Failure With Preserved Ejection Fraction: 2026 ACC Expert Consensus Decision Pathway. J Am Coll Cardiol. Published online July 23, 2026.
  3. Sandhu AT, et al. Disparity in the setting of incident heart failure diagnosis. Circ Heart Fail. 2021.